C13orf8, standing for Chromosome 13 Open Reading Frame 8, refers to a gene that encodes a protein whose function has not been well characterized in the existing scientific literature. As its name implies, it is located on the 13th chromosome and is identified as an open reading frame, suggesting that the genomic sequence is organized in such a way that it could be transcribed and translated into a functional protein.
The protein product of C13orf8 has yet to be extensively studied, which means that its role in cellular processes, interactions with other molecules, and potential involvement in signaling pathways remain largely speculative. Typically, proteins encoded by ORFs are identified through genome sequencing projects and require further experimental validation to ascertain their functions.Nevertheless, bioinformatics tools can be utilized to predict potential functions based on sequence homology, structural motifs, and domain analysis. These predictive models can suggest possible roles that C13orf8 might play, such as enzymatic activity, regulatory functions, or structural components of the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore, raising intracellular calcium levels, thereby potentially affecting calcium-dependent processes related to C13orf8. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can modulate various signaling pathways, possibly impacting C13orf8 function. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates insulin receptor signaling, influencing multiple metabolic pathways that might interact with C13orf8. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor, affecting PI3K/Akt signaling, which could indirectly modulate C13orf8 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, affecting cellular growth and metabolism pathways potentially linked to C13orf8. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which might alter ERK/MAPK signaling pathways, potentially influencing C13orf8. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, which could impact cellular stress responses related to C13orf8. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, potentially affecting signaling pathways relevant to C13orf8. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, potentially influencing ERK/MAPK signaling pathways linked to C13orf8. | ||||||